Ciclophosphamide, Vincristine, Myocet and Prednisone, With Rituximab in 1st-Line Treatment for Patients With No-Hodgkin B Lymphoma and Cardiovascular (CV) Risk

NCT00849355 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

No Hodgkin B Lymphoma

Interventions

DRUG: RCOMP-14 + rituximab

Sponsor

Asociacion Doctor Peset Para el Estudio de la Hematología

Collaborators

[object Object]
[object Object]